Mednet Logo

What gene mutations do you always test for prior to starting EGFR inhibitor therapy in metastatic colon cancer?

Would you advocate for a targeted gene approach or a fully comprehensive NGS panel?
Community PollStarted

What gene mutations do you always test for prior to starting EGFR inhibitor therapy in metastatic colon cancer?

105 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic
Answered on

At a minimum, I operate with pan-RAS, BRAF (yes, even for left sided tumors), MMR/MSI, RNA fusion/rearrangement, and HER2 testing prior to anti-EGFR therapy. Obviously, you would not want to give an EGFR inhibitor to a RAS mutated cancer, but similarly, I need to know the BRAF (particularly V600E) u...

Join for free or sign in to see the full answer